Federal Bill: HR 7050

This bill, titled the Homeopathic Drug Product Safety, Quality, and Transparency Act, aims to establish a distinct regulatory pathway for homeopathic drug products under the Federal Food, Drug, and Cosmetic Act (FD&C Act) to ensure consumer access to safe and quality products while providing transparency. It defines a "homeopathic drug product" as one containing only homeopathic ingredients, which are defined as those listed in the Homeopathic Pharmacopoeia of the United States or prepared according to specific homeopathic safety and quality standards. The bill exempts homeopathic drug products from most provisions of Chapter V of the FD&C Act, applying only specific sections related to adulteration, misbranding, and establishment registration, unless other provisions do not conflict with the new framework. It sets forth specific standards for adulteration, requiring compliance with the Homeopathic Pharmacopoeia